Mahajan Imaging, Neuberg Diagnostics plan 20 radiology centres across North India

The joint venture will expand across seven North Indian states with about 20 radiology centres, collection centres and two pathology centres of excellence in Delhi-NCR. The partners are targeting an integrated pathology, imaging and genomics network through organic growth and acquisitions.

— Source publishedMon, 31 Aug, 2026, 19:49 IST·First seen Mon, 31 Aug, 2026, 19:56 IST·Source The Hindu BusinessLine

What happened

Mahajan Imaging & Labs · Mahajan Imaging and Neuberg Diagnostics formed a North India joint venture to expand labs, collection centres and about 20 radiology

Key facts

  • Around 20 radiology centres
  • Seven North Indian states
  • Hundreds of collection centres
  • Two pathology centres of excellence in Delhi-NCR
  • Advanced diagnostics share expected to rise from less than 10% to more than 30%
  • Organised diagnostics sector projected to grow 12-14% in FY27

Why this matters

The joint venture creates a scaled North India consolidation vehicle, with organic rollout and acquisitions likely to make regional imaging, pathology and genomics assets attractive targets.

What to watch

  • Named centre openings, city pipeline and capital-expenditure or acquisition announcements.
  • Share of revenue from MRI, CT, PET-CT, molecular pathology, genomics and other advanced tests.
  • Turnaround-time metrics, radiologist/pathologist hiring and remote-reporting capacity.
  • Pricing actions or expansion responses from Dr Lal PathLabs, Metropolis, SRL, Redcliffe, hospital chains and regional diagnostic players.
  • Insurance reimbursement partnerships and corporate preventive-health contracts.
  • Evidence of cross-selling: pathology customers adopting imaging/genomics services or vice versa.
  • Announce the first Delhi-NCR pathology centres of excellence and initial radiology-centre locations.
  • Build a hub-and-spoke model linking collection centres to central pathology, genomics and specialist image-reporting hubs.
  • Pursue acquisitions or management partnerships with regional diagnostic labs and standalone imaging centres in target states.
  • Invest in digital booking, home sample collection, integrated patient records and remote radiology reporting to improve utilisation.
  • Expand B2B referral agreements with hospitals, oncologists, fertility clinics, corporate-health programs and insurers.